コンテンツへスキップ
Merck
  • High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia.

High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia.

Journal of medical microbiology (2013-03-23)
A A Alsultan, B A Evans, E A Elsayed, S I Al-Thawadi, A Y Al-Taher, S G B Amyes, A M Al-Dughaym, A Hamouda
要旨

Carbapenem-resistant Acinetobacter baumannii is becoming increasingly prevalent in patients with diabetes mellitus in the Middle East. We examined the relationship of these bacteria and their resistance mechanisms to the diabetic disease status of patients in Saudi Arabia. Susceptibilities of 271 isolates to carbapenems, tigecycline and colistin were determined, followed by detection of carbapenemase genes. A blaVIM gene was detected in ~95 % of isolates; blaOXA-23 and blaOXA-40 genes were also prevalent. Diabetic patients were significantly more likely to carry carbapenem-resistant isolates. Carbapenem-resistant A. baumannii is a serious problem in diabetic patients, and molecular detection of resistance mechanisms in these isolates is required.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ペニシリナーゼ Bacillus cereus由来, lyophilized powder, 1,500-3,000 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
β-ラクタマーゼ 緑膿菌由来, recombinant, expressed in E. coli
Sigma-Aldrich
β-ラクタマーゼ Enterobacter cloacae由来, Type IV, lyophilized powder, 0.2-0.6 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
ペニシリナーゼ Bacillus cereus由来, lyophilized, powder, white, ~13 U/mg
Sigma-Aldrich
β-ラクタマーゼ 蛍光菌Pseudomonas fluorescens由来, lyophilized powder, recombinant, expressed in E. coli